If the cancer comes back or gets worse, you may need to start treatment again. Physical Health The physical effects of hormone therapy for prostate cancer can impact your daily life. Cancer treatment affects people in different ways, so you may not have every side effect. You may notice: Ho...
like access to health care, rectal examinations, and PSA screening are all factors that influence the incidence of prostate cancer.The lowest rate of prostate cancer is seen in the Far East and on the Indian subcontinent, while the highest rates occur in North America, Australia and Western Eur...
prostate cancer doesn't work forever. The problem is that not all cancer cells need hormones to grow. Over time, these cells that aren't reliant on hormones will spread. If this happens, hormone therapy won't help anymore, and your doctor will need to shift to a different treatment ...
hormone therapy is the treatment of choice, rather than surgery. Surgery to reduce hormone levels may only be offered if the cancer has spread to other areas or is in a more advanced stage.
Hormone-targeted treatment has previously been linked to a higher risk of diabetes and heart disease. Azoulay and his colleagues took UK data on 10,250 men who were diagnosed with prostate cancer between 1997 and 2008. The men were followed for an average of just over four years after their...
arrhythmia and heart failure requiring hospitalisation as well as the risk of dying from these heart diseases by comparing the rates among the cancer patients with what's normal in the general Swedish population. Most patients got one of the three hormone treatment choices, but 38% got a combina...
(HealthDay)—Hormone therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease, a large-scale analysis of health data suggests. Men who underwentandrogen deprivation therapy(ADT) for their prostate cancer had nearly twice the risk of Alzheimer's, when ...
The treatment with anti-androgens can stop cancerous prostate cells from expanding. Some examples of anti-androgens that are used to treat prostate cancer include apalutamide and bicalutamide. They are also known as dark and flutamide and nilutamide. Also known as an androgen receptor antagonist or...
New treatment for advanced and hormone refractory prostate cancer (HRPC) with an oral cholesterol derivative (hydroxysterol 24-ethyl-cholestane- 3β,5α,6α-triol)e16531 Background: Hydroxysterols and oxysterols are oxygenated derivatives ... A Nachtnebel,J Breuer,R Joppi,... 被引量: 0发表...
An overview of hormone-associated cancers. Data on the aetiology of hormone-associated cancers are reviewed. Although for breast cancer many risk factors point to the relevance of hormonal factors, ... AB Miller - 《Cancer Research》 被引量: 45发表: 1978年 加载更多来源...